SEMA4A and hepatocellular carcinoma: Epithelial-mesenchymal transition (EMT) is a critical event during PCa metastasis13 and previous studies have demonstrated that SEMA4A confers doxorubicin resistance on hepatocellular carcinoma by inducing epithelial-mesenchymal transition (EMT)14.